SCHEMBL4846095

SCHEMBL4846095

O=C(OC[C@H]1O[C@H](O)[C@](O)(F)[C@@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ MAPT P10636 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ HIF1A Q16665 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ LGALS9 O00182 1/20 0.40
▸ LGALS1 P09382 1/20 0.40
▸ LGALS3 P17931 1/20 0.40
▸ LGALS7; LGALS7B P47929 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ PPM1B O75688 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30620960 1.00 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL2692294 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL16756807 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL13607676 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL1030464 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL16756809 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL6369092 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL13455914 0.90 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL2932130 0.89 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA
SCHEMBL29617526 0.89 ALDH1A1 (0.46) ALDH1A1MAPTPOLBMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7381820-B2 α-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2′-deoxy-2′-fluoro-β-d-arabinonucleoside YAMASA CORPORATION (JP) 2008-06-03 — — US disclosed
US-20070135627-A1 Alpha-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2'-deoxy-2'-fluoro-beta-d-arabinonucleoside KOHEL YAMADA, ETAL 2007-06-14 — — US disclosed
EP-1676853-A1 ALPHA-1-PHOSPHORYLATED-2-DEOXY-2-FLUOROARABINOSIDE AND PROCESS FOR PRODUCING 2 -DEOXY-2 -FLUORO-BETA-D-ARABINONUCLEOSID E YAMASA CORPORATION (JP) 2006-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135627-A1 Alpha-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2'-deoxy-2'-fluoro-beta-d-arabinonucleoside TYMP, PNP, DUT ALDH1A1 1265/4885MAPT 3630/4885POLB 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback